These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26835030)

  • 1. Defibrillation Testing During Defibrillator Implantation.
    Bänsch D
    Arrhythm Electrophysiol Rev; 2012 Sep; 1(1):51-53. PubMed ID: 26835030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NO Regular Defibrillation testing In Cardioverter Defibrillator Implantation (NORDIC ICD) trial: concept and design of a randomized, controlled trial of intra-operative defibrillation testing during de novo defibrillator implantation.
    Bänsch D; Bonnemeier H; Brandt J; Bode F; Svendsen JH; Felk A; Hauser T; Wegscheider K;
    Europace; 2015 Jan; 17(1):142-7. PubMed ID: 25107947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dilemma of ICD implant testing.
    Swerdlow CD; Russo AM; Degroot PJ
    Pacing Clin Electrophysiol; 2007 May; 30(5):675-700. PubMed ID: 17461879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).
    Healey JS; Hohnloser SH; Glikson M; Neuzner J; Mabo P; Vinolas X; Kautzner J; O'Hara G; VanErven L; Gadler F; Pogue J; Appl U; Gilkerson J; Pochet T; Stein KM; Merkely B; Chrolavicius S; Meeks B; Foldesi C; Thibault B; Connolly SJ;
    Lancet; 2015 Feb; 385(9970):785-91. PubMed ID: 25715991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial.
    Bänsch D; Bonnemeier H; Brandt J; Bode F; Svendsen JH; Táborský M; Kuster S; Blomström-Lundqvist C; Felk A; Hauser T; Suling A; Wegscheider K;
    Eur Heart J; 2015 Oct; 36(37):2500-7. PubMed ID: 26112885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses.
    Pires LA; Lehmann MH; Steinman RT; Baga JJ; Schuger CD
    J Am Coll Cardiol; 1999 Jan; 33(1):24-32. PubMed ID: 9935004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
    Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defibrillation testing of the implantable cardioverter defibrillator: when, how, and by whom?
    Pires LA
    Indian Pacing Electrophysiol J; 2007 Aug; 7(3):166-75. PubMed ID: 17684575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defibrillation threshold testing: is it necessary during implantable cardioverter-defibrillator implantation?
    Liu QM; Bai ZL; Liu ZJ; Li XP; Zhou SH
    Med Hypotheses; 2009 Feb; 72(2):147-9. PubMed ID: 18980811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
    J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of defibrillation threshold testing on effectiveness of the subcutaneous implantable cardioverter defibrillator.
    Peddareddy L; Merchant FM; Leon AR; Smith P; Patel A; El-Chami MF
    Pacing Clin Electrophysiol; 2018 Jun; ():. PubMed ID: 29893508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is ICD-programming for double intraoperative defibrillation threshold energy safe and effective during long-time follow-up? Results of a prospective randomized multicenter study (Low-Energy Endotak Trial--LEET)].
    Himmrich E; Liebrich A; Michel U; Neuzner J; Pitschner H; Heisel A; Vester E; Ganschov U; Jung J
    Z Kardiol; 1999 Feb; 88(2):103-12. PubMed ID: 10209831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability.
    Swerdlow CD; Peter CT; Kass RM; Gang ES; Mandel WJ; Hwang C; Martin DJ; Chen PS
    Circulation; 1997 Mar; 95(6):1497-504. PubMed ID: 9118518
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.